Concepedia
Statistics
Publications
6
Citations
444
H-Index
Active since
2015
Affiliations
Tufts University(Current)
AstraZeneca (United States)
University College London
Matt R. Kelley is an author at Tufts University specializing in neuroscience, life sciences, and neurotransmission.
Publications per year
2015–2021
KCC2 activity is critical in limiting the onset and severity of status epilepticus
Liliya Silayeva, Tarek Z. Deeb, Rochelle M. Hines et al. · Proceedings of the National Academy of Sciences · 2015 · 133 citations · Full text
Life Sciences, Neurobiology, Neuroscience +15
Selective Inhibition of KCC2 Leads to Hyperexcitability and Epileptiform Discharges in Hippocampal Slices and<i>In Vivo</i>
Sudhir Sivakumaran, Ross A. Cardarelli, Jamie Maguire et al. · Journal of Neuroscience · 2015 · 105 citations · Full text
Life Sciences, Neuroscience, Pharmacology +16
Expandable and Rapidly Differentiating Human Induced Neural Stem Cell Lines for Multiple Tissue Engineering Applications
Dana M. Cairns, Karolina Chwalek, Yvonne E. Moore et al. · Stem Cell Reports · 2016 · 86 citations · Full text
Life Sciences, Cell Biology, Neuroscience +17
Locally Reducing KCC2 Activity in the Hippocampus is Sufficient to Induce Temporal Lobe Epilepsy
Matt R. Kelley, Ross A. Cardarelli, Joshua L. Smalley et al. · EBioMedicine · 2018 · 51 citations · Full text
Life Sciences, Neurobiology, Neuroscience +13
Compromising KCC2 transporter activity enhances the development of continuous seizure activity
Matt R. Kelley, Tarek Z. Deeb, Nicholas J. Brandon et al. · Neuropharmacology · 2016 · 48 citations
Life Sciences, Neurobiology, Neuroscience +14
1–5 of 6